✦ LIBER ✦

Evaluation of a Novel Wound Closure Device: A Multicenter Randomized Controlled Trial

✍ Scribed by Adam J. Singer; Stuart Chale; Phil Giardano; Michael Hocker; Charles Cairns; Richard Hamilton; Milan Nadkarni; Angela M. Mills; Judd E. Hollander

Book ID: 109277379
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 391 KB
Volume: 18
Category: Article
ISSN: 1069-6563
DOI: 10.1111/j.1553-2712.2011.01177.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of a closure device on complicati

Effect of a closure device on complication rates in high-local-risk patients: Results of a randomized multicenter trial

✍ Bernard Chevalier; Bernard Lancelin; Rene Koning; Michel Henry; Antoine Gommeaux 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

A novel device reduces anal pain after r

A novel device reduces anal pain after rubber band ligation: a randomized controlled trial

✍ Lam, T. J.; Felt-Bersma, R. J. F. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 299 KB

A phase II randomized controlled trial o

A phase II randomized controlled trial of a novel male contraception, an intra-vas device

✍ L. Song; Y. Gu; W. Lu; X. Liang; Z. Chen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

A randomized, controlled study comparing

A randomized, controlled study comparing the cosmetic outcome of a new wound closure device with Prolene suture closing caesarean wounds

✍ Sven Juergens; Carolin Maune; Fatima Kezze; Thorsten Mohr; Katrin Scheuer; Peter 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 655 KB

A randomized controlled trial of the NEA

A randomized controlled trial of the NEAT expandable tip continence device

✍ H. Robinson; J. Schulz; C. Flood; L. Hansen 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 241 KB

A multicenter randomized placebo-control

A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome

✍ Roger Kurlan; Giovanna Crespi; Barbara Coffey; Kirsten Mueller-Vahl; Stephen Kov 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 730 KB

Background: Dopamine agonists could theoretically normalize the suspected central dopamine hypersensitivity in Tourette's syndrome. Methods: There was a multicenter randomized, placebo-controlled, double-blind clinical trial of pramipexole given for 6 weeks in 63 children and adolescents with Touret